Urology of Indiana Remains Cutting Edge in Prostate Cancer Detection


Urology of Indiana Remains Cutting Edge in Prostate Cancer Detection
Urology of Indiana Remains Cutting Edge in Prostate Cancer Detection

Urology of Indiana has recently introduced a new technology to help diagnose, sometimes difficult to find, Prostate Cancer. Artemis MRI/Ultrasound Semi Robotic Fusion Prostate Biopsy is now available for patients that have undergone a previous negative biopsy or are on Active Surveillance for prostate cancer.

It is estimated 25% to 40% of patients that undergo a standard template transrectal ultrasound prostate biopsy may have a false negative result. This is a well-known statistic amongst Urologists and represents a diagnostic dilemma for both patients and doctors. There are a number of tools Urologists have used to help determine if and when a patient should undergo a repeat biopsy. Urologists have used a number of “fancier” PSA type tests such as free and total PSA, PHI (Prostate Health Index), and 4k , and the PCA-3 to help determine who should undergo a repeat prostate biopsy. Recently, confirm MDX was introduced to look at the methylation patterns of certain genes in previous negative prostate biopsy tissue to help urologists decide on a repeat biopsy.

MRI-CAD (computer assisted diagnostics) is now emerging as a very helpful diagnostic tool as well. This imaging test allows radiologists and urologists to “peer inside” the prostate and get additional information about the size and any suspicious areas within the prostate and pelvis. When suspicious areas exist within the prostate, Artemis MRI/Ultrasound Fusion biopsies can be performed to target the suspicious areas. This exciting technology allows the Urologist to overlay (of Fuse) the real-time ultrasound images with the MRI-CAD. Any suspicious areas can then be targeted with great accuracy. This technique has been shown to increase detection rates of high risk prostate cancer and is an important tool. In addition, MRI/Ultrasound Fusion biopsy of the prostate has an emerging role in monitoring and managing patients who have already been diagnosed with prostate cancer and are on Active Surveillance.

Urology of Indiana is excited and proud to offer this new technology to our patients. Schedule an appointment with one of our doctors today to get examined.